Pathology of Urothelial Cancers
Dr. Donna E. Hansel, MD, PhD discusses molecular pathology in clinical practice and urothelial cancer treatment.
Read More
International Bladder Cancer Update
What Should I Do About Micropapillae? Do I Treat it Differently than Standard?
Dr. Donna E. Hansel, MD, PhD, addresses micropapillary and standard forms of bladder cancer, characteristics and treatment.
Read More
Methods and Guidelines to Stage and Grade (Low vs. High) UTUC and How Should We Treat
Seth P. Lerner, MD explores low-grade and high-grade upper tract urothelial carcinoma (UTUC), covering CT urography, MRI, and ureteroscopy.
Read More
FGFR Kinase Inhibitors and Other Novel Targets in the Treatment of Metastatic Urothelial Cancer
Parminder Singh, MD focuses on FGFR (fibroblast growth factor receptor) kinase inhibitors for metastatic urothelial cancer.
Read More
Targeted Therapy Combined with Immune Checkpoint Therapy: Is This the Wave of the Future?
Jean H. Hoffman-Censits, MD explores combining targeted therapy with immune checkpoint therapy to treat bladder cancer.
Read More